Recent news


Congratulations to the following researchers, who received grants from the Fonds de recherche du Québec - Santé!

  • Dr. Marie-Claude Geoffroy, chercheur-boursier clinicien Junior 1
  • Dr. Sherif Karama, chercheurs-boursiers cliniciens Junior 2
  • Dr. Martin Marc Lepage, Chaire de recherche
  • Dr. Laurence Roy, chercheur-boursier junior 1
  • Dr. Rob Whitley, chercheurs-boursier Junior 2   
Alain Brunet - La Presse 27 avril 2016

La Presse newspaper features an article on the front page about Alain Brunet's recent initiative to propose a new therapeutic approach for victims of the terrorist attacks in Paris who are suffering from Post-Traumatic Stress Disorder (PTSD).  The novel approach Alain Brunet proposed to the Paris hospitals will bring patients to recall their memories multiple times, while taking a drug, called propanolol, which will reduce the emotional burden associated with these painful memories...

Martin Lepage

Congratulations to Martin Lepage who was awarded a prestigious Research Chair from the Fonds de recherche du Québec - Santé (FRQ-S).  This prestigious program highlights the excellence of a limited number of experienced researchers selected by competition amongst the candidates exiting the "Chercheurs-boursiers" program.  Professor Lepage won one of only four FRQ-S Research Chairs attributed in the province this year.  The Research Chairs are worth $100 000 per year for four years.


Pedro Rosa-Neto

Neuroscientists have known for years that two abnormal proteins, called beta-amyloid and tau, accumulate in the brains of patients suffering from Alzheimer's disease.  However, they did not know which of the two proteins was driving the development of dementia associated with the disease.  New research done at the Douglas Hospital Research Centre by Pedro Rosa-Neto and his team and collaborators shows that both proteins have toxic effects in the brain.



Dr. Alain Brunet, from the research centre, is involved in an ambitious project, developped with Paris hospitals, to treat victims of terrorist attacks in Paris who are suffering of Post-Traumatic Stress Disorder, or PTSD.  The treatment protocol,  developed by Dr Brunet and his team, aims to reduce the intensity of a painful memory using a drug called propanolol.  During the treatment, the painful memory is recalled while taking the drug, which acts to inhibit the reconsolidation of the...


Bruno Giros explains some of the underlying biological differences that can explain why we are not equally susceptible to depression.  His recent research has shown that noradrenaline can play a role in certain patients, and suggests new therapeutic targets to treat depression.  Listen to Bruno Giros interviewed on the radio show Les Éclaireurs on Radio-Canada. (In French only)


Duncan Pedersen

Colleagues and friends at the Douglas Hospital Research Centre were very saddened to hear of the passing of Dr. Duncan Pedersen.  Dr. Pedersen had a sudden illness while in Chile for work on a project in Global Mental Health and passed away on January 27, 2016 . Our thoughts go out to his family and loved ones at this difficult time. 

A world renowned researcher, Dr. Pedersen was Associate Scientific Director of International Programs at the Douglas Institute and held the rank of...

Bruno Giros

The team of Bruno Giros, a researcher at the Douglas Mental Health University Institute and professor of psychiatry at McGill University, reports the first-ever connection between noradrenergic neurons and vulnerability to depression. Published in the journal Nature Neuroscience, this breakthrough paves the way for new depression treatments that target the adrenergic system.

Stressful life events—job loss, accident, death of a loved one—can trigger major depression in one...


Two Douglas researchers were recently awarded Canada Research Chairs: Mark Brandon, Canada Research Chair in Neural Circuits of Memory, and Sylvia Villeneuve, Canada Research Chair in Early Detection of Alzheimer’s Disease.  Both researchers are new recipients of Tier 2 Chairs, valued at $100,000 annually for five years with one opportunity for renewal.  Tier 2 chairs are for exceptional emerging researchers, acknowledged by their peers as having the potential to lead in their field.


Marie-Claude Geoffroy

Thinking about suicide or attempting suicide: victimized adolescents more at risk at 15

A new study published in the Journal of the American Academy of Child and Adolescent Psychiatry(JAACAP) by the team of Dr Marie-Claude Geoffroy, researcher at the CIUSSS de l'Ouest-de-l'Île-de-Montréal (Douglas mental health university institute, McGill group for suicide studies) and the Sainte-Justine hospital research...


McGill Logo

CIUSSS ouest montreal logo


  • Douglas Hospital
  • Dobell Pavillion
  • Brain imaging centre